Jpmorgan Chase & CO ANAPTYSBIO INC Transaction History

Jpmorgan Chase & CO

11,580

Previous 13,374 13.41%

Previous $0 NaN%

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	N/A	-1,794 Reduced 13.41%	11,580 $0
Q1 2024 May 10, 2024	SELL	N/A	-4,121 Reduced 23.56%	13,374 $0
Q4 2023 Feb 12, 2024	SELL	N/A	-10,917 Reduced 38.42%	17,495 $0
Q3 2023 Nov 14, 2023	BUY	N/A	905 Added 3.29%	28,412 $0
Q2 2023 Aug 11, 2023	SELL	N/A	-186,234 Reduced 87.13%	27,507 $0
Q1 2023 May 18, 2023	BUY	N/A	25,270 Added 13.41%	213,741 $0
Q1 2023 May 11, 2023	SELL	N/A	-25,613 Reduced 11.96%	188,471 $0
Q4 2022 Feb 13, 2023	SELL	N/A	-10,645 Reduced 4.74%	214,084 $6.63 Million
Q3 2022 Nov 14, 2022	SELL	N/A	-6,715 Reduced 2.9%	224,729 $5.73 Million
Q2 2022 Aug 11, 2022	SELL	N/A	-2,917 Reduced 1.24%	231,444 $4.7 Million
Q1 2022 May 11, 2022	SELL	N/A	-1,977 Reduced 0.84%	234,361 $5.8 Million
Q4 2021 Feb 10, 2022	SELL	N/A	-8,932 Reduced 3.64%	236,338 $8.21 Million
Q3 2021 Nov 12, 2021	BUY	N/A	245,270 New	245,270 $6.65 Million

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.